加味淸肺瀉肝湯이 고지방식이 비만생쥐의 체지방에 미치는 영향 = Effects of Gami-Cheongpyesagan-Tang on Body Fat in High Fat Diet-Fed Obese Mice

다국어 초록 (Multilingual Abstract)

Objectives: This study was designed to investigate the effect of Gami-cheongpyesagan-tangextract (GCST) on high fat diet-induced obesity in rats.
Methods: The mice were divided into six groups; normal diet control, high fat diet control (HFD),HFD＋GCST administrated group (100, 200, and 400 mg/kg) and olistat-admistrated group.
Obesity was induced by high fat diet (45%) for 7 weeks in mice, and GCST was administratedorally every day for 7 weeks. The body weight, food intake, and serological markers such as totalcholesterol, triglyceride, lipid contents, leptin, adiponectin and glutamic oxaloacetictransaminase/glutamic pyruvic transaminase were measured in mice. The mRNA expression ofobese-associating genes such as sterol regulatory element-binding protein (SREBP)-1c, fattyacid synthase (FAS), stearoyl-CaP desaturase (SCD-1), peroxisome proliferator-activatedreceptor (PPAR)-, COA oxidase (ACO), and carnitine palmitoyltransferase (CPT-1) wasanalyzed by reverse transcription polymerase chain reaction.
Results: The administration of GCST at 400 mg/kg, significantly reduced the increase of bodyweight and food intake as well as food efficiency compared to HFD group. GCST decreased theserum levels of triglyceride, total cholesterol, low-density lipoprotein-cholesterol, leptin in HFDcontrol group and inhibited lipid accumulation in liver and adipose tissues, but did not increasehigh-density lipoprotein-cholesterol. In the liver tissues of GCST administrated HFD group, themRNA levels of SREBP-1c, FAS and SCD-1 were decreased and the mRNA levels of PPAR-,ACO, and CPT-1 were increased.
Conclusions: These results indicate that GCST could improve high fat diet induced obesitythrough inhibiting the hyperlipidemia in fatty Liver. It suggest that GCST may be used clinically fordeclining the accumultion of body fat with hyperlipidemia.

참고문헌 (Reference)

1 황미자, "한국에서 비만치료에 쓰이는 한약에 대한 문헌 연구-2000년 이후 발표된 논문을 중심으로" 한방재활의학과학회 16 (16): 65-81, 2006

2 김은영, "태음인 청폐사간탕이 lipase 활성저해 및 db/db mouse의 체중감량, 혈장지질, UCP 1, 2 발현에 미치는 영향" 사상체질의학회 19 (19): 171-185, 2007

3 박영주, "청폐사간탕(淸肺瀉肝湯)의 혈소판 응집억제 작용에 대한 in vitro 연구" 대한한방내과학회 31 (31): 714-721, 2010

4 김석기, "지방 및 탄수화물 흡수억제 메커니즘을 활용한 비만 개선 식이 연구" 한국식품과학회 35 (35): 519-526, 2003

5 김경수, "비만의 약물치료: 허가된 약물을 중심으로" 대한비만학회 21 (21): 197-202, 2012

6 강순아, "비만관련 한약혼합제제의 비만에 대한 효과" 대한본초학회 18 (18): 8-64, 2003

7 박원형, "비만(肥滿) 변증 연구에 대한 고찰(국내 연구 중심으로)" 한방재활의학과학회 24 (24): 83-93, 2014

8 최동준, "급성기 중풍 환자에 대한 청폐사간탕의 임상적 효능" 대한한의학회 23 (23): 659-664, 2002

9 황지호, "熱多寒少湯과 淸肺瀉肝湯의 활용에 대한 임상적 연구" 한국한의학연구원 14 (14): 101-106, 2008

10 정춘근, "淸肺瀉肝湯이 糖尿誘發 흰쥐의 腦虛血損傷에 미치는 影響" 대한한의학회 26 (26): 217-230, 2005

11 김정열, "淸肺瀉肝湯이 CCl4로 誘發된 휜쥐의 肝損傷에 미치는 影響" 사상체질의학회 17 (17): 130-141, 2005

12 안훈모, "淸肺瀉肝湯과 YKK012의 항암제 CPT-11과 병용투여 시 대장암 성장억제에 미치는 효과" 대한본초학회 30 (30): 33-42, 2015

13 윤영식, "淸心蓮子湯이 비만 유도 생쥐의 체중 및 혈청 지질에 미치는 영향" 대한한의학방제학회 22 (22): 123-139, 2014

14 김길수, "太陰調胃湯과 그 加減方의 항비만 및 항고지혈증 효과에 관한 연구" 대한한방신경정신과학회 18 (18): 57-74, 2007

15 Hwang MY, "The study of oriental pothological physiology on obesity" 8 (8): 77-83, 1984

16 Heo SY, "The study and treatment of East-West medicine on obesity" 7 (7): 272-283, 1997

17 Darlington GJ, "The role of C/EBP genes in adipocyte differentiation" 273 : 30057-30060, 1998

18 Visscher TL, "The public health impact of obesity" 22 : 355-375, 2001

19 Song MY, "The clinical study about the effect of Chugpaesagan-tang and Taeumjoui-tang on Taeumin obesity after fasting therapy" 8 (8): 34-56, 1998

20 Lee GN, "The clinical pathology file" Uihakmunhwasa 155-199, 2000

21 Kim HG, "The bibliographical study on causes, mechanisms and the chief virtues on obesity" 1 (1): 61-71, 1992

22 Björntorp P, "The associations between obesity, adipose tissue distribution and disease" 723 : 121-134, 1988

23 Berg AH, "The adipocyte-secreted protein Acrp30 enhances hepatic insulin action" 7 : 947-953, 2001

24 Wilson JD, "Textbook of endocrinology" W. B. Saunders Company 1081-1098, 1985

25 Huang J, "Sustained activation of PPAR α by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice" 26 (26): 628-638, 2012

26 Avram AS, "Subcutanous fat in normal and diseased status: 2. Anatomy and physiology of white and brown adipose tissue" 53 : 671-683, 2005

27 Cameron PJ, "Stearoyl coenzyme A desaturase enzyme activity and mRNA levels are not different in subcutaneous adipose tissue from angus and American wagyu steers" 72 : 2624-2628, 1994

28 Horton JD, "SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver" 109 : 1125-1131, 2002

29 Yang KM, "Relationship between the assessment of obesity and cardiovascular diseases" 7 (7): 1-8, 2002

30 Fasshauer M, "Regulation of adipokines and insulin resistance" 46 : 1594-1603, 2003

31 Fruebis J, "Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice" 98 : 2005-2010, 2001

32 Hong SG, "Protective effects of Chungpesagan-tang against ischemia/reperfusion induced cell injury" 54 (54): 111-117, 2000

33 Maeda N, "PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein" 50 : 2094-2099, 2001

34 Schoonjans K, "PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene" 15 : 5336-5348, 1996

35 Satoh N, "Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients" 27 : 2488-2490, 2004

36 The Society of Korean Medicine Rehabilitation, "Korean medicine rehabilitation" Koonja Publishing Inc 298-317, 2015

37 Combs TP, "Induction of adipocyte complement-related protein of 30kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization" 143 : 998-1007, 2002

38 Weyer C, "Hypoadiponectinemia in obesity and type 2diabetes: close association with insulin resistance and hyperinsulinemia" 86 : 1930-1935, 2001

39 Shin MG, "Herbal medicine" Younglim Publishing 322-, 2006

40 Nepokroeff CM, "Fatty acid synthase from rat liver" 35 : 37-44, 1975

41 Huh SY, "Experimental study on the effect of Chungpesagantang in obese rats" 8 (8): 106-118, 1998

42 Koo JS., "Effects of Chungpyesagantang on the diabetic rats induced by streptozotocin" 1 (1): 227-248, 1997

43 Song YS, "Effects of Bangkihwangkitang, Bangkihwangkitang with Lycii fructus and Lycii fructus on the weight of obese rats" 1 (1): 25-43, 1991

44 Lee ES, "Effects of Bangkihwangkitang on adipose tissue of liver and epididymis and serum lipid" 5 (5): 1-10, 1995

45 Bae JH, "Effect of Cheongpesagan-tang on the changes of the weight, plasma and UCP mRNA expression in obese SD rats induced high fat feed" 12 (12): 133-156, 2002

46 Lee JM, "Dongeuisusebowon" Henglim Publishing Inc 7-13, 1986

47 Won JS, "Dongeuisasangshinpyeon" Jonghapeuiwonsa 66-67, 1974

48 Jeong BS, "Dohaehyangyak unabridged dictionary" Younglim Publishing 116-119, 1990

49 Lee HK, "Diseases associated with obesity" 23 (23): 341-346, 1990

50 Diamond FB Jr, "Correlates of adiponectin and the leptin/adiponectin ratio in obese and non-obese children" 17 : 1069-1075, 2004

51 Min HG, "Clinical endocrinology" Korea medicine 475-487, 1990

52 Song YK, "Clinical application of ma huang in the obesity treatment" 7 (7): 1-7, 2007

53 Xu H, "Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance" 112 (112): 1821-1830, 2003

54 Tomkin GH, "Atherosclerosis, diabetes and lipoproteins" 8 : 1015-1029, 2010

55 Jin KS, "Analysis of the tendency to research for obesity" Graduate School of Daejeon University 2004

56 Kim DL, "An experimental study of the effect by Chongshimyonjatang and Chongpyesagantang on immune response and anti-allergic reaction to rats and mice" 14 : 131-160, 1991

57 Ahima RS, "Adipose tissue as an endocrine organ" 11 : 327-332, 2000

58 Lindsay RS, "Adiponectin and development of type 2diabetes in the Pima Indian population" 360 : 57-58, 2002

59 Folch J, "A simple method for the isolation and purification of total lipid from animal tissues" 226 : 497-509, 1975

60 Moon SH, "A relationshipof the obesity and body composition analysisby Sasang constitution" 12 (12): 1-10, 2002

61 Frings CS, "A colorimetric method for determination of total serum lipids based on the sulfo- phospho-vanillin reaction" 53 : 89-91, 1970